Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market

Accuray Incorporated announced that the company has received 510 clearance from the U.S. Food and Drug Administration for its VitalHold™* breast package on the Radixact® System.